Feb 18 2025 48 mins
In this episode we discuss obinutuzumab for lupus nephritis and anti-CD19 CAR T Cell therapy for autoimmune rheumatic disease.
Links to the B-Cell Breakaway Scouting Reports:
- Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship Program
- CD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship Program
- STRAP trial, by the Emerging EULAR Network (EMEUNET)
Links to theMednet.org Q&As about this region:
- In the treatment of lupus nephritis, which patients may benefit from the use of rituximab or other B-cell depleting agents during induction?
- What are the potential barriers to the widespread use of obinutuzumab in proliferative lupus nephritis?
- How do you envision incorporating CAR-T therapy into your clinical practice?
- Does synovial biopsy provide diagnostic value in undifferentiated inflammatory arthritis?
To learn more about RheumMadness:
https://sites.duke.edu/rheummadness/
Subscribe to our newsletter:
https://lists.duke.edu/sympa/subscribe/rheummadness
Find us on social media:
Bluesky: @rheummadness.bsky.social
Instagram: https://www.instagram.com/rheummadness/
X: Follow #RheumMadness
Intro/outro music: Cheery Monday by Kevin MacLeod
Link: https://incompetech.filmmusic.io/song/3495-cheery-monday
License: http://creativecommons.org/licenses/by/4.0/